ClinicalTrials.gg
CompletedNCT07166250Updated Nov 19, 2026

Comparison of the Effects of Quadratus Lumborum Block and Retrolaminar Block on Postoperative Pain in Lumbar Disc Herniation Surgery

An interventional study of Quadratus Lumborum Block and Retrolaminar Block in Lumbar Disc Herniation and Postoperative Pain, sponsored by Kocaeli University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Kocaeli University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Oct 2024, registered Sep 2025).
Updated Nov 19, 2026Now CompletedStart date moved+4 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
82
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 121 studies in Intervertebral Disc Displacement with a site in Turkey — 22 open to participants now, 28 under way, none of them phase 3. Intervertebral Disc Displacement · Turkey.

Enrollment
20th of 86
82 · median 60
Started
2024
with 24 others
No phase
85 of 121
11 open now
Registered
87th of 121
by date

Among the 121 studies in Intervertebral Disc Displacement with a site in Turkey, this one is the 20th largest by enrollment of the 86 interventional ones that give a count, is one of 25 that started in 2024, is one of 85 with no phase, and was the 87th registered.

Intervertebral Disc Displacement

474 studies on the registry are indexed under Intervertebral Disc Displacement; 98 are open to participants now.

Browse Intervertebral Disc Displacement studies →

Open to participants now

22 of the 121 studies in Intervertebral Disc Displacement with a site in Turkey are open now. Recruiting first, the newest first:

17 more — sign in →

All 22 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 48 Intervertebral Disc Displacement studies recruiting now, 20 (42%) set no upper age limit and 24 (50%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 121 studies in Intervertebral Disc Displacement with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to compare the analgesic efficacy of quadratus lumborum block (QLB) and retrolaminar block (RLB) in patients undergoing lumbar disc herniation surgery. Both regional anesthesia techniques are increasingly used for postoperative pain management, but there is limited evidence directly comparing their effectiveness. The primary outcome is postoperative opioid consumption, while secondary outcomes include postoperative pain scores

Read the detailed description

Effective postoperative pain management is essential in patients undergoing lumbar disc herniation surgery. Regional anesthesia techniques, such as quadratus lumborum block (QLB) and retrolaminar block (RLB), have been increasingly used as alternatives or adjuncts to systemic analgesics. QLB provides analgesia by targeting the thoracolumbar fascia and spreading to the paravertebral space, whereas RLB is considered a simpler and potentially safer approach with similar analgesic potential.

This randomized controlled clinical trial is designed to compare the efficacy and safety of QLB and RLB for postoperative pain control. Adult patients scheduled for elective lumbar disc herniation surgery under general anesthesia will be randomized into two groups. One group will receive ultrasound-guided QLB, and the other group will receive ultrasound-guided RLB before surgical incision.

The primary outcome is total postoperative morphine consumption during the first 24 hours after surgery. Secondary outcomes include postoperative pain intensity measured using the Numerical Rating Scale (NRS) at multiple time points within the first 24 hours, the need for rescue analgesia, postoperative nausea and vomiting (PONV), and block-related complications.

03

Conditions studied

  • Lumbar Disc Herniation
  • Postoperative Pain

Keywords

  • Quadratus Lumborum Block
  • Retrolaminar Block
  • Spine Surgery Analgesia
  • Opioid Consumption
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 18-65 years
  • (ASA) physical status I-II-III
  • Scheduled for elective lumbar disc herniation surgery under general anesthesia
  • Willing to participate and provide written
  • Patients scheduled for elective lumbar disc herniation surgery

Exclusion criteria

Exclusion Criteria:

  • Patients requiring emergency surgery
  • classification IV-V
  • Known coagulopathy
  • Ongoing anticoagulant therapy
  • History of allergy to local anesthetics
  • Localized infection at the block injection site
  • Presence of spinal, paraspinal, or regional deformities at the block area
  • Inability to understand or use the verbal pain rating scale
  • Chronic use of analgesic medications
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
82 participants (actual)

Study arms

  • Experimental
    Quadratus Lumborum Block

    Patients randomized to this group will receive an ultrasound-guided quadratus lumborum block (QLB) with local anesthetic injection before surgical incision for postoperative pain management.

    Procedure: Quadratus Lumborum Block

  • Experimental
    Retrolaminar Block

    Patients randomized to this group will receive an ultrasound-guided retrolaminar block (RLB) with local anesthetic injection before surgical incision for postoperative pain management.

    Procedure: Retrolaminar Block

Interventions

  • ProcedureQuadratus Lumborum Block

    Ultrasound-guided quadratus lumborum block performed preoperatively using local anesthetic injection at the thoracolumbar fascia for postoperative analgesia in lumbar disc herniation surgery.

  • ProcedureRetrolaminar Block

    Ultrasound-guided retrolaminar block performed preoperatively using local anesthetic injection into the retrolaminar space for postoperative analgesia in lumbar disc herniation surgery

06

What researchers measure

Primary outcomes

  1. Total Postoperative Opioid Consumption

    Total cumulative amount of intravenous morphine consumed (in milligrams) via patient-controlled analgesia (PCA) device.

    Time frame: Within the first 24 hours after surgery

Secondary outcomes

  1. Postoperative pain intensity (Numerical Rating Scale, NRS 0-10)

    Pain intensity will be assessed using the Numerical Rating Scale (NRS), where 0 = no pain and 10 = worst imaginable pain.

    Time frame: Within the first 24 hours after surgery

  2. Need for rescue analgesia

    Number of patients requiring additional rescue analgesic medication during the postoperative period.

    Time frame: Within the first 24 hours after surgery

07

Study locations

1 site
  • Kocaeli University Hospital
    Kocaeli, 41000, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Dec 2025, 14 months.

Of 178 non-industry interventional studies with no phase under Intervertebral Disc Displacement, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's 14 months is above that.

Counting every sponsor, half of 191 studies reached it within 12 months; a quarter within 5 and three quarters within 27.

Start moved once since we started tracking on Sep 25, 2026: May 2024 → Oct 2024, on Nov 19, 2026.

Completion moved once since we started tracking on Sep 25, 2026: May 2026 → Apr 2026, on Oct 22, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Sep 3, 2025
First posted
Sep 10, 2025
StartActual
Oct 4, 2024was May 2024
Primary completionActual
Dec 26, 2025
CompletionActual
Apr 20, 2026was May 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Active, not recruiting→Completed
changed Oct 22, 2026
Start date
May 16, 2024→Oct 4, 2024
Nov 19, 2026
Primary completion
Dec 16, 2025→Dec 26, 2025 (actual)
Oct 22, 2026
Study completion
May 15, 2026→Apr 20, 2026 (actual)
Oct 22, 2026
Enrollment
84 (estimated)→82 (actual)
Oct 22, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Postoperative pain intensity (NRS score)Now Total Postoperative Opioid ConsumptionTime frame: Within the first 24 hours after surgery
Oct 22, 2026
Secondary outcomes
2 added, 2 removed
What changed in the outcomes
  • AddedPostoperative pain intensity (Numerical Rating Scale, NRS 0-10)Time frame: Within the first 24 hours after surgery
  • AddedNeed for rescue analgesiaTime frame: Within the first 24 hours after surgery
  • RemovedTotal opioid consumptionTime frame: 24 hours after surgery
  • RemovedTime to first analgesic requestTime frame: 24 hours after surgery
Oct 22, 2026
Show all 2 updates
  1. Nov 19, 2026
    Start date May 16, 2024→Oct 4, 2024
  2. Oct 22, 2026
    Active, not recruiting→Completed
    Primary completion Dec 16, 2025→Dec 26, 2025 (now actual)
    Study completion May 15, 2026→Apr 20, 2026 (now actual)
    Enrollment 84 (estimated)→82 (actual)
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Postoperative pain intensity (NRS score)Now Total Postoperative Opioid ConsumptionTime frame: Within the first 24 hours after surgery
    Secondary outcomes 2 added, 2 removed
    What changed in the outcomes
    • AddedPostoperative pain intensity (Numerical Rating Scale, NRS 0-10)Time frame: Within the first 24 hours after surgery
    • AddedNeed for rescue analgesiaTime frame: Within the first 24 hours after surgery
    • RemovedTotal opioid consumptionTime frame: 24 hours after surgery
    • RemovedTime to first analgesic requestTime frame: 24 hours after surgery
    + 3 other changes: verification date, description and criteria formatting

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07166250
Lead sponsor
Kocaeli University
Responsible party
Nermin Kandemir (research assistant, Kocaeli University) — Principal investigator
First posted
Sep 10, 2025
Start date
Oct 4, 2024
Primary completion
Dec 26, 2025
Completion
Apr 20, 2026
Last update
Nov 19, 2026

Study contacts

dilek icli, prof. dr.
principal investigator · Kocaeli University, Department of Anesthesiology and Reanimation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion